Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normal Saline Flushes at 12 and 24 Hours Intervals
NCT02221024Phase 3Completed
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Jul 2011
- Primary completion
- Sep 2013
- Countries
- 1
01
Overview
Phase 3, randomised trial (2 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoint: Number of participants with peripheral intravenous catheter patency. Started Jul 2011; status: completed.
Beyond the preview
Go deeper on NCT02221024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02221024.